InvestorsHub Logo
Followers 77
Posts 4453
Boards Moderated 0
Alias Born 09/01/2015

Re: ApollyonZ post# 15029

Monday, 06/17/2019 9:17:24 AM

Monday, June 17, 2019 9:17:24 AM

Post# of 71147
Nice, only company that showed revenue #s which I listed below which double of Stem Cell Group and market cap is $392mill

Market cap: $392.71 million; current share price: $11.25
Vericel bases its treatment in tissue collection from the patient. Its two lead products, Carticel and Epicel, are seeking to treat cartilage defects in the knee and patients with burns greater than or equal to 30 percent of total body surface area respectively.
The company initiated a collaboration with the private company Innovative Cellular Therapeutics. Vericel has the intention to use the collaboration to bring its cell therapy products to patients in Asia.
In March, the company announced positive 2017 financial results with an 18 percent increase to $63.9 million from $54.4 million year over y
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.